Evolution of the Average Target: Xylem Inc.

Evolution of the Target Price: Xylem Inc.

Changes in Analyst Recommendations: Xylem Inc.

18c.Qq6u4p5PvKWQki3JD1FzZIpZVLxv8yXBdZlsjczwmRE.G5bduM0X2NXJ-xWGazMyEMAeH8tWvGeXJ_ZB2IPdy0ImmuXQzgGOx-f7FQ~62c949d68253035c9bf705f20cc5f756
08-24 Jefferies Adjusts Price Target on Xylem to $150 From $145 MT
08-13 UBS Adjusts Price Target on Xylem to $138 From $135, Keeps Neutral Rating MT
08-12 Argus Adjusts Price Target on Xylem to $140 From $125, Maintains Buy Rating MT
07-30 UBS Adjusts Price Target on Xylem to $135 From $129, Maintains Neutral Rating MT
07-29 Xylem's Guidance Boost Driven by Buybacks, Bolt-On Acquisition, RBC Says MT
07-29 RBC Raises Price Target on Xylem to $164 From $159, Keeps Outperform Rating MT
07-29 Deutsche Bank Adjusts Xylem Price Target to $151 From $149, Maintains Buy Rating MT
07-29 JPMorgan Adjusts Price Target on Xylem to $137 From $130, Maintains Neutral Rating MT
07-29 Barclays Adjusts Price Target on Xylem to $159 From $154, Maintains Overweight Rating MT
07-29 Baird Adjusts Price Target on Xylem to $165 From $163, Maintains Outperform Rating MT
07-29 Stifel Adjusts Price Target on Xylem to $160 From $157, Maintains Buy Rating MT
07-29 Goldman Sachs Adjusts Price Target on Xylem to $160 From $153, Maintains Buy Rating MT
07-29 Citigroup Adjusts Price Target on Xylem to $172 From $168, Maintains Buy Rating MT
07-29 Mizuho Adjusts Price Target on Xylem to $130 From $124, Maintains Neutral Rating MT
07-21 JPMorgan Downgrades Xylem to Neutral From Overweight, Cuts Price Target to $130 From $140 MT
07-20 Jefferies Adjusts Price Target on Xylem to $145 From $140, Maintains Buy Rating MT
07-20 Stifel Adjusts Price Target on Xylem to $157 From $159, Maintains Buy Rating MT
07-16 RBC Capital Adjusts Price Target on Xylem to $159 From $157, Maintains Outperform Rating MT
07-14 Xylem Likely Approaching Growth Inflection, Oppenheimer Says MT
07-06 UBS Adjusts Xylem Price Target to $129 From $133 MT
06-25 Xylem Shares Rise After Jefferies Upgrade MT
06-25 Jefferies Upgrades Xylem to Buy From Hold, Adjusts Price Target to $140 From $130 MT
05-19 Argus Adjusts Price Target on Xylem to $125 From $150, Maintains Buy Rating MT
04-29 Mizuho Adjusts Price Target on Xylem to $124 From $138, Maintains Neutral Rating MT
04-29 Oppenheimer Adjusts Price Target on Xylem to $158 From $160, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+18.53%
+21.41%
+18.11%
+24.92%
+21.25%
+27.11%
+39.75%
+45.64%
+2.45%
Average +24.35%
Weighted average by Cap. +22.63%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
110.11USD
Average target price
153.88USD
Spread / Average Target
+39.75%
High Price Target
180.00USD
Spread / Highest target
+63.47%
Low Price Target
129.00USD
Spread / Lowest Target
+17.16%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AAA